| Company Name: | Aceto Corporation | | Ticker Symbol: | ACET | | | WWW Address: | www.aceto.com | | CEO: | Vincent G. Miata | | No. of Employees: | 221 | | Common Issue Type: | CS | | Business Description: | The company is engaged in the sourcing, quality assurance, regulatory support, marketing and distribution of chemically derived pharmaceuticals, biopharmaceuticals, specialty chemicals and crop protection products.
|
| | | Industry Information: | DRUGS - Drug Manufacturers - Major [more like this] |
|
| Price | Day Change | Bid | Ask | Open | High | Low | Volume | | 5.24 |  0.05 | 5.03 | 5.74 | 5.18 | 5.24 | 5.15 | 100207 |
| Market Cap (mil) | Shares Outstanding (mil) | Beta | EPS | DPS | P/E | Yield | 52-Wks-Range |
| 130.0 | 24.8 | 1.01 | 0.35 | 0.20 | 25.0 | 3.8 | 11.70 - 4.86 |
|
| KEY FIGURES (Latest Twelve Months - LTM) | | Yesterday's Close | 5.24 | $ | | PE Ratio - LTM | 25.0 | |
| Market Capitalisation | 129.8 | mil |
| Latest Shares Outstanding | 24.8 | mil |
| Earnings pS (EPS) | 0.35 | $ |
| Dividend pS (DPS) | 0.20 | ¢ |
| Dividend Yield | 3.8 | % |
| Dividend Payout Ratio | 57 | % |
| Revenue per Employee | 1,459,937 | $ |
| Effective Tax Rate | 32.2 | % |
| Float | 24.3 | mil |
| Float as % of Shares Outstanding | 98.3 | % |
| Foreign Sales | 137 | mil |
| Domestic Sales | 185 | mil |
| Selling, General & Adm/tive (SG&A) as % of Revenue | 14.00 | % |
| Research & Devlopment (R&D) as % of Revenue | 0.00 | % |
| Gross Profit Margin | 16.9 | % |
| EBITDA Margin | 3.0 | % |
| Pre-Tax Profit Margin | 2.4 | % |
| Assets Turnover | 1.5 | % |
| Return on Assets (ROA) | 2.5 | % |
| Return on Equity (ROE) | 3.5 | % |
| Return on Capital Invested (ROCI) | 3.3 | % |
| Current Ratio | 4.0 | |
| Leverage Ratio (Assets/Equity) | 1.4 | |
| Interest Cover | 52.8 | |
| Total Debt/Equity (Gearing Ratio) | 0.06 | |
| LT Debt/Total Capital | 5.0 | % |
| Working Capital pS | 5.13 | $ |
| Cash pS | 2.05 | $ |
| Book-Value pS | 5.84 | $ |
| Tangible Book-Value pS | 5.31 | $ |
| Cash Flow pS | 0.29 | $ |
| Free Cash Flow pS | 0.44 | $ |
 |
| KEY FIGURES (LTM): Price info |
| Price/Book Ratio | 0.90 | |
| Price/Tangible Book Ratio | 0.99 | |
| Price/Cash Flow | 18.2 | |
| Price/Free Cash Flow | 12.0 | |
| P/E as % of Industry Group | 113.0 | % |
| P/E as % of Sector Segment | 148.0 | % |
| | | Balance Sheet (at a glance) in Millions |
| | | | | | DIVIDEND INFO | | Dividend Declared Date | 05/10/2009 |
| Dividend Ex-Date | 06/10/2009 |
| Dividend Record Date | 06/14/2009 |
| Dividend Pay Date | 06/25/2009 |
| Dividend Amount | 100 |
| Type of Payment | Cash Payment |
| Dividend Rate | 0.20 |
| Current Dividend Yield | 3.8 |
| 5-Y Average Dividend Yield | 2.4 |
| Payout Ratio | 57.0 |
| 5-Y Average Payout Ratio | 43.0 |
|  | | Share price performance previous 3 years |
|
 | | | Share price performance intraday |
|
 | |
| |
| PRICE/VOLUME | High | Low | Close | % Price Chg | % Price Chg vs. Mkt. | Avg. Daily Vol | Total Vol |
| 1 Week | - | - | - | 2.7 | 103 | 1,690 | 6,601 |
| 4 Weeks | 6.25 | 5.00 | 6.14 | -14.7 | 84 | 1,374 | 27,474 |
| 13 Weeks | 7.38 | 5.00 | 6.92 | -24.3 | 71 | 1,465 | 93,788 |
| 26 Weeks | 7.45 | 5.00 | 5.27 | -0.6 | 81 | 1,480 | 187,982 |
| 52 Weeks | 11.70 | 4.86 | 8.13 | -35.5 | 47 | 1,526 | 382,924 |
| YTD | 11.70 | 4.86 | - | -47.7 | 43 | 1,486 | 334,415 |
| Moving Average | 5-Days | 10-Days | 10-Weeks | 30-Weeks | 200-Days | Beta (60-Mnth) | Beta (36-Mnth) |
| 5.26 | 5.38 | 6.17 | 6.40 | 6.48 | 1.01 | 0.82 |
|
| |
| GROWTH RATES | 5-Year
Growh | R² of 5-Year Growth | 3-Year
Growth |
| Revenue | 1.56 | 20.0 | 2.04 |
| Income | -5.95 | 24.2 | -7.36 |
| Dividend | 12.15 | 72.1 | 9.72 |
| Capital Spending | -12.72 | NA | 46.80 |
| R&D | 0.00 | NA | 0.00 |
| Normalized Inc. | -6.63 | NA | -8.02 |
| | | CHANGES | YTD vs.
Last YTD | Curr Qtr vs.
Qtr 1-Yr ago | Annual vs.
Last Annual |
| Revenue % | -24.8 | -24.8 | -10.3 |
| Earnings % | -78.0 | -78.0 | -36.0 |
| EPS % | -77.8 | -77.8 | -35.2 |
| EPS $ | -0.14 | -0.14 | -0.19 |
|
| |
| SOLVENCY RATIOS | | SHORT-TERM SOLVENCY RATIOS (LIQUIDITY) |
| Net Working Capital Ratio | 60.70 |
| Current Ratio | 3.7 |
| Quick Ratio (Acid Test) | 2.4 |
| Liquidity Ratio (Cash) | 1.24 |
| Receivables Turnover | 5.0 |
| Average Collection Period | 72 |
| Working Capital/Equity | 88.1 |
| Working Capital pS | 5.03 |
| Cash-Flow pS | 0.42 |
| Free Cash-Flow pS | 0.60 |
| FINANCIAL STRUCTURE RATIOS |
| Altman's Z-Score Ratio | 3.85 |
| Financial Leverage Ratio (Assets/Equity) | 1.5 |
| Debt Ratio | 31.1 |
| Total Debt/Equity (Gearing Ratio) | 0.06 |
| LT Debt/Equity | 0.06 |
| LT Debt/Capital Invested | 11.3 |
| LT Debt/Total Liabilities | 13.4 |
| Interest Cover | 130.9 |
| Interest/Capital Invested | 0.06 |
| | | | VALUATION RATIOS | | MULTIPLES |
| PQ Ratio | 1.18 |
| Tobin's Q Ratio | 0.63 |
| Current P/E Ratio - LTM | 25.00 |
| Enterprise Value (EV)/EBITDA | 9.84 |
| Enterprise Value (EV)/Free Cash Flow | 26.47 |
| Dividend Yield | 3.8 |
| Price/Tangible Book Ratio - LTM | 0.99 |
| Price/Book Ratio - LTM | 0.90 |
| Price/Cash Flow Ratio | 18.2 |
| Price/Free Cash Flow Ratio - LTM | 12.0 |
| Price/Sales Ratio | 0.43 |
| P/E Ratio (1 month ago) - LTM | 31.5 |
| P/E Ratio (26 weeks ago) - LTM | 8.5 |
| P/E Ratio (52 weeks ago) - LTM | 12.1 |
| 5-Y High P/E Ratio | 33.4 |
| 5-Y Low P/E Ratio | 10.7 |
| 5-Y Average P/E Ratio | 18.5 |
| Current P/E Ratio as % of 5-Y Average P/E | 135 |
| P/E as % of Industry Group | 113.0 |
| P/E as % of Sector Segment | 148.0 |
| Current 12 Month Normalized P/E Ratio - LTM | 25.0 |
| PER SHARE FIGURES |
| LT Debt pS | 0.34 |
| Current Liabilities pS | 1.89 |
| Tangible Book Value pS - LTM | 5.31 |
| Book Value pS - LTM | 5.84 |
| Capital Invested pS | 6.06 |
| Cash pS - LTM | 2.05 |
| Cash Flow pS - LTM | 0.29 |
| Free Cash Flow pS - LTM | 0.44 |
| Earnings pS (EPS) | 0.35 |
| | | | OPERATING RATIOS | | PROFITABILITY RATIOS |
| Free Cash Flow Margin | 4.62 |
| Free Cash Flow Margin 5YEAR AVG | 1.42 |
| Net Profit Margin | 2.7 |
| Net Profit Margin - 5YEAR AVRG. | 3.2 |
| Equity Productivity | 2.28 |
| Return on Equity (ROE) | 6.1 |
| Return on Equity (ROE) - 5YEAR AVRG. | 8.2 |
| Capital Invested Productivity | 2.15 |
| Return on Capital Invested (ROCI) | 5.7 |
| Return on Capital Invested (ROCI) - 5YEAR AVRG. | 7.9 |
| Assets Productivity | 1.50 |
| Return on Assets (ROA) | 4.2 |
| Return on Assets (ROA) - 5YEAR AVRG. | 5.5 |
| Gross Profit Margin | 16.9 |
| Gross Profit Margin - 5YEAR AVRG. | 18.1 |
| EBITDA Margin - LTM | 3.0 |
| EBIT Margin - LTM | 2.5 |
| Pre-Tax Profit Margin | 3.9 |
| Pre-Tax Profit Margin - 5YEAR AVRG. | 4.8 |
| Effective Tax Rate | 32.2 |
| Effective Tax Rate - 5YEAR AVRG. | 30.4 |
| EFFICIENCY RATIOS |
| Cash Conversion Cycle | 148 |
| Revenue per Employee | 1,459,937 |
| Net Income per Employee | 39,045 |
| Average Collection Period | 63 |
| Receivables Turnover | 5.0 |
| Day's Inventory Turnover Ratio | 85 |
| Inventory Turnover | 4.2 |
| Inventory/Sales | 16.9 |
| Accounts Payble/Sales | 7.79 |
| Assets/Revenue | 0.67 |
| Net Working Capital Turnover | 2.59 |
| Fixed Assets Turnover | 9.54 |
| Total Assets Turnover | 1.5 |
| Revenue per $ Cash | 5.59 |
| Revenue per $ Plant | 75.93 |
| Revenue per $ Common Equity | 2.28 |
| Revenue per $ Capital Invested | 2.15 |
| Selling, General & Adm/tive (SG&A) as % of Revenue | 13.5 |
| SG&A Expense as % of Revenue - 5YEAR AVRG. | 13.0 |
| Research & Devlopment (R&D) as % of Revenue | 0.0 |
| R&D Expense as % of Revenue - 5YEAR AVRG. | 0.0 |
|
|  
|
| |
 |  |